Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

The focus of its treatments includes patients with Parkinson's disease, Rett Syndrome, Amyotrophic Lateral Sclerosis, schizoprenia, and neuropathic pain.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Number of employees : 23 persons.
Sales per Businesses
20142015Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Drugs1.58100%1.9279.1% +21.76%
Sales per Regions
20142015Delta
CHF (in Million)%CHF (in Million)%
Global1.58100%1.9279.1% +21.76%
Managers
NameAgeSinceTitle
Stefan Weber522005Chief Executive Officer, Director & IR Contact
Ulrich Köstlin, PhD652013Non-Executive Chairman
Roberto Galli-2002Vice President-Finance
Ravi Anand, MD602005Chief Medical Officer
Patrick J. Langlois, PhD722008Independent Non-Executive Director
Robert Leslie Holland MD, PhD622013Independent Non-Executive Director
Bo Jesper Hansen MD, PhD592013Independent Non-Executive Director
Joseph Donald deBethizy, PhD662014Independent Non-Executive Director
Luca Benatti, PhD562014Independent Non-Executive Director
Marco Caremi602002Executive Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 15,773,168 11,552,138 73.2% 0 0.0% 73.2%
Shareholders
NameEquities%
Investor AB 1,772,817 11.2%
Gefim SpA 1,311,957 8.32%
Aviva Plc 1,097,054 6.96%
JPMorgan Asset Management (UK) Ltd. 358,613 2.27%
UBS AG (Investment Management) 276,546 1.75%
Polar Capital LLP 162,834 1.03%
Union Investment Privatfonds GmbH 149,140 0.95%
Aviva Investors Global Services Ltd. 121,616 0.77%
Credit Suisse AG 109,427 0.69%
Deka Investment GmbH 101,500 0.64%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
NEWRON PHARMACEUTICALS..11.17%343
AMGEN, INC.19.01%128 555
GILEAD SCIENCES, INC.-3.13%92 143
CELGENE CORPORATION3.21%91 979
REGENERON PHARMACEUTIC..-1.67%38 296
ACTELION LTD22.45%28 792
VERTEX PHARMACEUTICALS..16.37%21 348
GENMAB A/S21.40%11 807
TESARO INC38.27%9 982
EXELIXIS, INC.45.81%6 213
HUALAN BIOLOGICAL ENGI..--.--%4 936
TONGHUA DONGBAO PHARMA..-2.92%4 398
NEUROCRINE BIOSCIENCES..11.32%3 722
BIOCON LTD17.16%3 338
BLUEBIRD BIO INC26.90%3 328
ULTRAGENYX PHARMACEUTI..9.34%3 233
CHINA BIOLOGIC PRODUCT..2.45%2 961
INTERCEPT PHARMACEUTIC..6.70%2 957
BEIJING SL PHARMACEUTI..--.--%2 838
PEPTIDREAM INC-13.32%2 691
KITE PHARMA INC18.13%2 623
Sector Bio Therapeutic Drugs
Newron Pharmaceuticals SpA : Connections
DFC Langlois
Azanta A/S
Oxford Gene Technology IP Ltd.
Assobiotec
Early Clinical Development Consulting Ltd.
White City Consulting ApS
European School of Management & Technology GmbH
Italian Angels For Biotech
Karolinska Development AB (Private Equity)
Constantia Flexibles Group GmbH
Wellington Partners GmbH
PJL Consulting
NOXXON Pharma AG
Constantia Flexibles AG
CMC Contrast AB
EryDel SpA
MipSalus ApS
Universitätsklinikum Würzburg
Orphazyme ApS
The European Association for Bioindustries
Company contact information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2017 People , Fundamentals and Ownership